Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Pierre Vermette | M | - | 19 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Scovell | M | - |
University of Leeds
| 8 years |
| Don B. Rix | M | 93 | - | |
| Trevor Hallam | M | 65 |
University of Leeds
| 4 years |
| Hun Soon Lim | M | 68 |
University of Leeds
| 4 years |
| Nordin bin Mohamad Desa | M | 68 |
University of Leeds
| 4 years |
| M. Jinnat Mian | M | 75 |
University of Leeds
| 21 years |
| Philip Tracy | M | 74 |
University of Leeds
| 4 years |
| David Coates | M | - |
University of Leeds
| 3 years |
| John Rankin | M | - |
University of Leeds
| 4 years |
| Geoffrey F. Weir | M | - |
University of Leeds
| 4 years |
| Terence Holohan | M | - |
University of Leeds
| 4 years |
| Chin Leong Yap | M | 67 |
University of Leeds
| 4 years |
| Jeremy James Field | M | 68 |
University of Leeds
| 4 years |
| Chee Keong Yap | M | 68 |
University of Leeds
| 4 years |
| Philip Richard Holmes Newsome | M | - |
University of Leeds
| 4 years |
| Michael Robert Davidson | M | 68 |
Apotex, Inc.
 Apotex, Inc. Pharmaceuticals: MajorHealth Technology Apotex, Inc. operates as a generic pharmaceutical company that offers medicines. It engages in research and development, bioequivalence, and clinical studies. The company was founded by Dr. Bernard Sherman in 1974 and is headquartered in Toronto, Canada. | 14 years |
| Michael Norton | M | - |
University of Leeds
| 4 years |
| Peter Soutar Low | M | - |
University of Leeds
| 4 years |
| Tim Oliver | M | - |
University of Leeds
| 4 years |
| Pak Man Lau | M | 69 |
University of Leeds
| 4 years |
| Eric Evlyn Illsley | M | 69 |
University of Leeds
| 3 years |
| John Dominic Battle | M | 73 |
University of Leeds
| 4 years |
| Matthew Robert Ferrey | M | 69 |
University of Leeds
| 4 years |
| Zulkifli bin Ibrahim | M | 68 |
University of Leeds
| 4 years |
| Ai Lin Ong | F | 68 |
University of Leeds
| 4 years |
| Andrew James Seaton | M | 69 |
University of Leeds
| 4 years |
| Chi Ming Lau | M | 74 |
University of Leeds
| 4 years |
| Michael Ash | M | - |
Apotex, Inc.
Apotex, Inc. Pharmaceuticals: MajorHealth Technology Apotex, Inc. operates as a generic pharmaceutical company that offers medicines. It engages in research and development, bioequivalence, and clinical studies. The company was founded by Dr. Bernard Sherman in 1974 and is headquartered in Toronto, Canada. | 11 years |
| Henryk Klakurka | M | 73 |
Apotex, Inc.
Apotex, Inc. Pharmaceuticals: MajorHealth Technology Apotex, Inc. operates as a generic pharmaceutical company that offers medicines. It engages in research and development, bioequivalence, and clinical studies. The company was founded by Dr. Bernard Sherman in 1974 and is headquartered in Toronto, Canada. | 4 years |
| Siew Hai Wong | M | 73 |
University of Leeds
| 4 years |
| Zulkifli Mohamad bin Ibrahim | M | 65 |
University of Leeds
| 4 years |
| Siew Siong Ngian | M | 71 |
University of Leeds
| 4 years |
| John S. Williams | M | - |
University of Leeds
| 4 years |
| Paul Raymond Boldy | M | 67 |
University of Leeds
| 3 years |
| David Wong | M | 69 |
University of Leeds
| 4 years |
| Peter Molyneux Hill | M | - |
University of Leeds
| 3 years |
| John M. Langstaff | M | - |
Apotex, Inc.
Apotex, Inc. Pharmaceuticals: MajorHealth Technology Apotex, Inc. operates as a generic pharmaceutical company that offers medicines. It engages in research and development, bioequivalence, and clinical studies. The company was founded by Dr. Bernard Sherman in 1974 and is headquartered in Toronto, Canada. | - |
| Teck Yuen Lee | M | 66 |
University of Leeds
| 4 years |
| Fahar Merchant | M | - |
KS Avicenna, Inc.
| 1 years |
| Kevin Harry Emsley | M | 71 |
University of Leeds
| 2 years |
| Christopher M. Snowden | M | - |
University of Leeds
| 4 years |
| Choon Kong Yong | M | 71 |
University of Leeds
| 4 years |
| Roger D. Friedberger | M | 72 |
University of Leeds
| 4 years |
| Roland Frank Gerard Phelps | M | 71 |
University of Leeds
| 4 years |
| Robin Widdup | M | - |
University of Leeds
| 4 years |
| Anne Siddell | F | - |
University of Leeds
| 4 years |
| Yuen Wai Tsang | M | 68 |
University of Leeds
| 4 years |
| Bradley Thompson | M | 67 |
Hawker Resources, Inc.
 Hawker Resources, Inc. Contract DrillingIndustrial Services Hawker is a exploration and production company, cast aside its drug candidates to explore the Western Canada Sedimentary Basin for natural gas and oil. Hawker Resources acquired fellow explorers Southward Energy and ZORIN Exploration in 2003 and 2004, respectively. In 2005 it also acquired Iteration Energy, an oil and gas company, and is divesting its Lavoy area assets. After the divestiture, the company will have proved reserves of about 3.8 million barrels of oil equivalent and proved plus probable reserves of 5.7 million barrels of oil equivalent. | 5 years |
| Douglas A. Ball | M | - |
Hawker Resources, Inc.
Hawker Resources, Inc. Contract DrillingIndustrial Services Hawker is a exploration and production company, cast aside its drug candidates to explore the Western Canada Sedimentary Basin for natural gas and oil. Hawker Resources acquired fellow explorers Southward Energy and ZORIN Exploration in 2003 and 2004, respectively. In 2005 it also acquired Iteration Energy, an oil and gas company, and is divesting its Lavoy area assets. After the divestiture, the company will have proved reserves of about 3.8 million barrels of oil equivalent and proved plus probable reserves of 5.7 million barrels of oil equivalent. | - |
| Richard Eassom | M | - |
University of Leeds
| 4 years |
| Istaqbal Mehdi | M | - |
University of Leeds
| 2 years |
| Michael W. Jones | M | - |
Hawker Resources, Inc.
Hawker Resources, Inc. Contract DrillingIndustrial Services Hawker is a exploration and production company, cast aside its drug candidates to explore the Western Canada Sedimentary Basin for natural gas and oil. Hawker Resources acquired fellow explorers Southward Energy and ZORIN Exploration in 2003 and 2004, respectively. In 2005 it also acquired Iteration Energy, an oil and gas company, and is divesting its Lavoy area assets. After the divestiture, the company will have proved reserves of about 3.8 million barrels of oil equivalent and proved plus probable reserves of 5.7 million barrels of oil equivalent. | 2 years |
| Michael Bretherton | M | 68 |
University of Leeds
| 4 years |
| Raphe Patmore | M | - |
University of Leeds
| 4 years |
| Nadim Al-Muasher | M | 73 |
University of Leeds
| 4 years |
| Robert Hayim | M | 69 |
University of Leeds
| 4 years |
| Colin Howard Glass | M | 67 |
University of Leeds
| 4 years |
| Che Halin bin Mohammad Hashim | M | 69 |
University of Leeds
| 4 years |
| Karl M. Ibadulla | M | - |
University of Leeds
| 4 years |
| Samuel Chiang | M | - |
University of Leeds
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 51 | 83.61% |
| Canada | 10 | 16.39% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David J. Cox
- Personal Network
